Literature DB >> 18251745

Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin.

Betina Werner1, Martina Bresch, Fabiane Mulinari Brenner, Hermenio Cavalcante Lima.   

Abstract

BACKGROUND: Acitretin has been shown to be effective for psoriasis treatment. Its mechanism of action is not completely understood, and there are few studies focusing on histological and immunohistochemical differences before and after treatment of psoriasis with acitretin.
METHODS: This is a prospective study of 17 patients with plaque psoriasis treated with acitretin for 4 months with biopsies taken before and after therapy. Histological features and immunohistochemical reactions to cytokeratin (CK) 10, CK16, CK19, Ki67 and CD1a were evaluated and compared.
RESULTS: There were nine men and eight women with median age of 47 years. Epidermal thickness, CK16 positivity, Ki67 and CD1a-positive cell index reduced after treatment (p < 0.01). Suprapapillary plate thickness stayed the same (p > 0.05) although the epidermal/suprapapillary thickness ratio was significantly higher before treatment (p < 0.01). CK10 positivity was lower and a thicker basal cell layer was seen in the epidermis before treatment (p < 0.01). CK19 was negative in all cases.
CONCLUSIONS: Acitretin therapy improved histological and immunohistochemical features typical of psoriasis. In psoriasis, suprapapillary plates are not thin, but the epidermal/suprapapillary thickness ratio is increased. Basal cell layer is expanded in psoriasis. Langerhans' cells were less frequent after treatment, and that finding has to be investigated further to determine its role in acitretin mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18251745     DOI: 10.1111/j.1600-0560.2007.00800.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  5 in total

1.  Methotrexate treatment provokes apoptosis of proliferating keratinocyte in psoriasis patients.

Authors:  Tamilselvi Elango; Anand Thirupathi; Swapna Subramanian; Purushoth Ethiraj; Haripriya Dayalan; Pushpa Gnanaraj
Journal:  Clin Exp Med       Date:  2016-07-19       Impact factor: 3.984

2.  Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo-in vivo evaluation study.

Authors:  Irhan Ibrahim Abu Hashim; Noha Fawzy Abo El-Magd; Ahmed Ramadan El-Sheakh; Mohammed Fawzy Hamed; Abd El-Gawad Helmy Abd El-Gawad
Journal:  Int J Nanomedicine       Date:  2018-02-20

3.  Oral Alitretinoin for Patients with Refractory Prurigo.

Authors:  Bo Young Chung; Ji Young Um; Seok Young Kang; Min Je Jung; Jin Cheol Kim; In-Suk Kwak; Chun Wook Park; Hye One Kim
Journal:  Medicina (Kaunas)       Date:  2020-11-09       Impact factor: 2.430

4.  Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis.

Authors:  Engin Sezer; Almut Böer-Auer; Emel Cetin; Fatma Tokat; Emel Durmaz; Sedef Sahin; Umit Ince
Journal:  Dermatol Pract Concept       Date:  2015-07-31

5.  Alitretinoin in Dermatology-An Update.

Authors:  Aditya Kumar Bubna
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.